Synthesis of novel benzohydrazone-oxadiazole hybrids as β-glucuronidase inhibitors and molecular modeling studies.

[1]  H. Subramanya,et al.  Benzimidazole derivatives as potential dual inhibitors for PARP-1 and DHODH. , 2015, Bioorganic & medicinal chemistry.

[2]  N. Ismail,et al.  Novel 2,5-disubtituted-1,3,4-oxadiazoles with benzimidazole backbone: a new class of β-glucuronidase inhibitors and in silico studies. , 2015, Bioorganic & medicinal chemistry.

[3]  N. Ismail,et al.  Synthesis of novel inhibitors of α-glucosidase based on the benzothiazole skeleton containing benzohydrazide moiety and their molecular docking studies. , 2015, European journal of medicinal chemistry.

[4]  H. Ullah,et al.  Triazinoindole analogs as potent inhibitors of α-glucosidase: synthesis, biological evaluation and molecular docking studies. , 2015, Bioorganic chemistry.

[5]  N. Ismail,et al.  Synthesis of novel derivatives of 4-methylbenzimidazole and evaluation of their biological activities. , 2014, European journal of medicinal chemistry.

[6]  M. Choudhary,et al.  Synthesis and β-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones. , 2014, Bioorganic & medicinal chemistry.

[7]  S. Perveen,et al.  Phenoxyacetohydrazide Schiff Bases: β-Glucuronidase Inhibitors , 2014, Molecules.

[8]  Naveen Kosar,et al.  Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton. , 2014, European journal of medicinal chemistry.

[9]  S. Akhtar,et al.  2-(2′-Pyridyl) benzimidazole derivatives and their urease inhibitory activity , 2014, Medicinal Chemistry Research.

[10]  Sajjad Ali,et al.  Structure-based design, synthesis and biological evaluation of β-glucuronidase inhibitors , 2014, Journal of Computer-Aided Molecular Design.

[11]  Khalid Mohammed Khan,et al.  Evaluation of bisindole as potent β-glucuronidase inhibitors: synthesis and in silico based studies. , 2014, Bioorganic & medicinal chemistry letters.

[12]  M. Choudhary,et al.  Synthesis and in vitro urease inhibitory activity of N,N'-disubstituted thioureas. , 2014, European journal of medicinal chemistry.

[13]  B. Poojary,et al.  Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents. , 2012, European journal of medicinal chemistry.

[14]  F. Rahim,et al.  6-Nitrobenzimidazole derivatives: potential phosphodiesterase inhibitors: synthesis and structure-activity relationship. , 2012, Bioorganic & medicinal chemistry.

[15]  Zaheer-ul-Haq,et al.  Synthesis of novel inhibitors of β-glucuronidase based on benzothiazole skeleton and study of their binding affinity by molecular docking. , 2011, Bioorganic & medicinal chemistry.

[16]  Hoyun Lee,et al.  A 4-aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells , 2009, European Journal of Medicinal Chemistry.

[17]  Hoyun Lee,et al.  Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity. , 2009, Bioorganic & medicinal chemistry.

[18]  Robert M. Jones,et al.  GPR119 agonists for the treatment of type 2 diabetes , 2009, Expert opinion on therapeutic patents.

[19]  A. Gómez-Barrio,et al.  Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation. , 2009, European journal of medicinal chemistry.

[20]  A. Husain,et al.  Synthesis of novel 1,3,4-oxadiazole derivatives and their biological properties , 2009, Acta pharmaceutica.

[21]  G. Peters,et al.  Design of new drug molecules to be used in reversing multidrug resistance in cancer cells. , 2009, Current cancer drug targets.

[22]  J. Warmus,et al.  2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles-O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase). , 2008, Bioorganic & medicinal chemistry letters.

[23]  Chong-Hwan Chang,et al.  Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity. , 2008, Journal of medicinal chemistry.

[24]  Hoyun Lee,et al.  The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine. , 2008, Bioorganic & medicinal chemistry.

[25]  M. Court,et al.  Effect of the β‐glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP‐glucuronosyltransferases , 2008, The Journal of pharmacy and pharmacology.

[26]  H. Saji,et al.  Development of novel beta-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole. , 2008, Bioorganic & medicinal chemistry.

[27]  B. Meunier,et al.  Hybrid molecules with a dual mode of action: dream or reality? , 2008, Accounts of chemical research.

[28]  K. Bothara,et al.  Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives. , 2008, Bioorganic & medicinal chemistry.

[29]  Mohamed Ashraf Ali,et al.  Oxadiazole mannich bases: synthesis and antimycobacterial activity. , 2007, Bioorganic & medicinal chemistry letters.

[30]  V. Buchta,et al.  Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activities. , 2007, Bioorganic & medicinal chemistry.

[31]  M. Amir,et al.  Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation properties of ibuprofen derivatives , 2007, Acta pharmaceutica.

[32]  Thiam Hong Ang,et al.  Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents. , 2006, Antiviral research.

[33]  S. Gaonkar,et al.  Synthesis and antimicrobial studies of a new series of 2-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]-5-substituted-1,3,4-oxadiazoles. , 2006, European journal of medicinal chemistry.

[34]  A. Malikzay,et al.  Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines. , 2006, Bioorganic & medicinal chemistry letters.

[35]  B. V. Ashalatha,et al.  Synthesis of Some New 2‐(6‐Methoxy‐2‐Naphthyl)‐ 5‐Aryl‐1,3,4‐Oxadiazoles as Possible Non‐steroidal Anti‐inflammatory and Analgesic Agents , 2005, Archiv der Pharmazie.

[36]  L. Qiu,et al.  Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents. , 2005, Journal of medicinal chemistry.

[37]  A. Zarghi,et al.  Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles. , 2005, Bioorganic & medicinal chemistry letters.

[38]  A. Shafiee,et al.  Synthesis and anticonvulsant activity of new 2-substituted-5- [2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles. , 2004, Bioorganic & medicinal chemistry letters.

[39]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[40]  S. Croft,et al.  Antikinetoplastid activity of 3-aryl-5-thiocyanatomethyl-1,2,4-oxadiazoles. , 2004, Bioorganic & medicinal chemistry.

[41]  S. Schroeder,et al.  Structure-activity relationship in the oxazolidinone-quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action. , 2003, Bioorganic & medicinal chemistry letters.

[42]  Atta-ur-Rahman,et al.  β-N-Cyanoethyl Acyl Hydrazide Derivatives : A New Class of β-Glucuronidase Inhibitors , 2002 .

[43]  G. Sahin,et al.  Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones. , 2002, Farmaco.

[44]  S. Bhanot,et al.  The chemical and biological aspects of fluoroquinolones: reality and dreams. , 2001, Current pharmaceutical design.

[45]  L. W. Spruce,et al.  Design and synthesis of new orally active nonpeptidic inhibitors of human neutrophil elastase. , 2000, Journal of medicinal chemistry.

[46]  J. Backman,et al.  The Role of β-Glucuronidase in Drug Disposition and Drug Targeting in Humans , 1997 .

[47]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[48]  E. LaVoie,et al.  Bioisosterism: A Rational Approach in Drug Design. , 1996, Chemical reviews.

[49]  F. Scott Mathews,et al.  Structure of human β-glucuronidase reveals candidate lysosomal targeting and active-site motifs , 1996, Nature Structural Biology.

[50]  R. D. Dyer,et al.  Novel 1,2,4-oxadiazoles and 1,2,4-thiadiazoles as dual 5-lipoxygenase and cyclooxygenase inhibitors. , 1992, Journal of medicinal chemistry.

[51]  F E Blaney,et al.  Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor. , 1991, Journal of medicinal chemistry.

[52]  R. Dotson,et al.  Synthesis and diuretic profile of 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine, an amiloride-type diuretic. , 1980, Journal of medicinal chemistry.

[53]  H. Gonick,et al.  Urinary -glucuronidase activity in renal disease. , 1973, Archives of internal medicine.

[54]  Gerald Weissmann,et al.  MECHANISMS OF LYSOSOMAL ENZYME RELEASE FROM LEUKOCYTES EXPOSED TO IMMUNE COMPLEXES AND OTHER PARTICLES , 1971, The Journal of experimental medicine.

[55]  R. Cutler,et al.  Failure of Urinary Beta-Glucuronidase Activity to Localize the Site of Urinary Tract Infection , 1971 .

[56]  R. W. Beard,et al.  Estimation of Beta-Glucuronidase Activity in Urinary-Tract Infection , 1967 .

[57]  H. L. Yale,et al.  2-amino-5-substituted 1,3,4-oxadiazoles and 5-imino-2-substituted delta-2-1,3,4-oxadiazolines. A group of novel muscle relaxants. , 1966, Journal of medicinal chemistry.

[58]  D A Pitkeathly,et al.  A Study of β-Acetylglucosaminase and Acid Phosphatase in Pathological Joint Fluids* , 1966, Annals of the rheumatic diseases.

[59]  N. Bank,et al.  URINARY BETA-GLUCURONIDASE ACTIVITY IN PATIENTS WITH URINARY-TRACT INFECTION. , 1965, The New England journal of medicine.

[60]  D. Williams,et al.  Enzyme Activity in Relation to Cancer , 1957, British Journal of Cancer.

[61]  Gerhard Klebe,et al.  Adding calorimetric data to decision making in lead discovery: a hot tip , 2010, Nature Reviews Drug Discovery.

[62]  Lynn A. Hyde,et al.  Discovery of amide and heteroaryl isosteres as carbamate replacements in a series of orally active gamma-secretase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[63]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.